Connect with us
Prague Gaming & TECH Summit 2024

Fintech PR

Graph Blockchain Welcomes Christian Scovenna as President and COO

Published

on

Reading Time: 2 minutes

Toronto, Ontario–(Newsfile Corp. – March 18, 2020) – Graph Blockchain Inc. (CSE: GBLC) (“Graph” or the “Company“) is pleased to announce that Christian Scovenna has joined the Company as President and COO, effective March 18, 2020.

“Christian’s appointment represents a strong addition to our team, and I am excited to welcome him on board,” says Govinda Butcher, Graph’s CEO. “His experience in building and running public companies, especially in the cannabis industry, will be a tremendous asset as we build out Graph’s psychedelic e-commerce marketplace. We see many similarities between the psychedelic sector today and the cannabis space 6-7 years ago. Having a seasoned capital markets President and COO in place will greatly benefit our company and shareholders as it will allow me to focus on the buildout and execution of our strategy.”

COO & President Christian Scovenna added: “I am honoured to be joining GBLC and the team as we look to pivot into the psychedelics sector and create the first global psychedelic e-commerce marketplace. My commitment to the BOD and our shareholders is to develop a revenue-based model that serves to enhance shareholder value.”

Christian Scovenna is a highly experienced C-Suite Executive with over 13 years of capital market experience working with both, private and public microcap companies in Canada. He has held numerous Board positions with publicly traded resource, pharmaceutical and cannabis companies structuring deals/acquisitions and raising capital In his previous engagement with Mojave Jane Brands Inc. (formerly, High Hampton Holdings Corp.) (CSE: JANE), he was instrumental in building the company as one of the original founders and was a key member of the management team as interim CEO and Senior VP Corporate Finance while also serving on the board as a director. He currently serves as Director for Revive Therapeutics (RVV.C), Pasofino Gold Limited (formerly Enforcer Gold Corp.) (TSXV: VEIN) and Tevano Payment Systems (Private Co.) as VP Of Corporate Development.

About Graph Blockchain Inc.

The Company develops leading-edge private blockchain business intelligence and data management solutions that it will implement into a blockchain supported e-commerce marketplace for the sale of psychedelic and ancillary products in legal jurisdictions.

Additional Information on the Company is available at: www.graphblockchain.com

For further information, please contact:

Govinda Butcher – CEO
Phone: (416) 522-6688
Email: [email protected]

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Such statements may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53566

Fintech PR

Telkomsel and Huawei Inaugurate Indonesia’s First 5G Smart Warehouse and 5G Innovation Center

Published

on

telkomsel-and-huawei-inaugurate-indonesia’s-first-5g-smart-warehouse-and-5g-innovation-center

JAKARTA, Indonesia, March 19, 2024 /PRNewswire/ — Leading telecommunications provider Telkomsel and global ICT solutions provider Huawei have inaugurated Indonesia’s first 5G Smart Warehouse and 5G Innovation Center in Bekasi Regency, West Java. This landmark facility showcases the potential of 5G technology to transform warehouse management, boosting operational efficiency and creating new opportunities for the logistics industry to support the digital economy leapfrog towards the Golden Indonesia Vision 2045.

The inauguration ceremony was officiated by Mr. Long, CEO of Huawei Indonesia, and attended by dignitaries including Dr. Ir. Ismail MT, Director General of Resources Management and Equipment of Posts and Informatics, Ministry of Communication and Informatics; Indra Mardiatna, Telkomsel Director of Network; Derrick Heng, Telkomsel Marketing Director; Mahendra Rianto, Chairman of the Indonesian Logistics Association; and representatives from Bandung Institute of Technology, Telkom University, and other representatives from industry partners.

Director General Dr. Ir. Ismail MT emphasized, “Huawei’s 5G Smart Warehouse stands as both a wake-up call and a quintessential model for the ecosystem, demonstrating the immediate and seamless integration of 5G technology into digitalization efforts. This integration evidently yields innovative solutions that extend benefits beyond the logistics sector to a multitude of industries. Such advancements are attainable solely through the concerted efforts of all stakeholders, united in the pursuit of accelerating the nation’s digital transformation.”

Mr. Long, CEO of Huawei Indonesia, highlighted Huawei’s commitment to supporting the government and industry players to unlock Indonesia’s digital opportunities. “At last year’s Solo 5G summit, together with industry partners, we pledged to boost the 5G ecosystem. The 5G Smart Warehouse is a testament to the value that 5G technology can bring to traditional industries in Indonesia,” he stated.

Indra Mardiatna, Telkomsel Director of Network remarked, “Aligned with Indonesia’s vision of pioneering innovations that propel the nation’s advancement, Telkomsel remains steadfast in its commitment to deliver superior connectivity, pioneering solutions, and inventive services designed to foster empowerment and catalyze expansive opportunities for entrepreneurial growth within the country. We are optimistic that the deployment of the 5G Smart Warehouse alongside the 5G Innovation Center’s conceptual solutions will inaugurate a transformative era for professionals within the logistics sector, particularly by enhancing managerial competencies and amplifying the operational efficacy of warehousing systems. With the unwavering support of the government, courtesy of the Ministry of Communication and Information, and through synergistic partnerships with stakeholders including Huawei, industry associations, and the academic community, Telkomsel pledges to persist in championing the rapid evolution of Indonesia’s digital commerce and economic landscape, with a focus on inclusive and sustainable progress”

The digital economy, which is expected to be a major catalyst for Indonesia’s economy in the future, requires the backing of an efficient and effective logistics industry. Based on data from the Ministry of National Development Planning/Bappenas, Indonesia’s logistics costs have decreased from 23.5% to 14.29% of gross domestic product by 2023.

Benefits of the 5G Smart Warehouse 

Indonesia's first 5G Smart Warehouse

The 5G Smart Warehouse leverages advanced technologies like IoT and big data analytics to streamline operations, enhance safety and security, increase efficiency, and reduce energy consumptions and lower potential unexpected losses.

Warehouse managers can use digital twins and real-time data analysis to optimize inventory management and prevent stockouts.

The 5G network also facilitates swift and accurate communication between staff and autonomous guided vehicles (AGVs), ensuring efficient goods movement. Additionally, intelligent security systems powered by video and infrared sensors ensure warehouse safety.

Huawei’s 5G BTS technology powering the warehouse features an energy consumption of just 5 watts, equivalent to a single energy-saving light bulb, making it a sustainable solution for the future.

Photo – https://mma.prnewswire.com/media/2365771/Telkomsel_Huawei_inaugurating_Indonesia_s_5G_Smart_Warehouse_togther_partners.jpg

Photo – https://mma.prnewswire.com/media/2365772/Indonesia_s_5G_Smart_Warehouse.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/telkomsel-and-huawei-inaugurate-indonesias-first-5g-smart-warehouse-and-5g-innovation-center-302092422.html

Continue Reading

Fintech PR

Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Published

on

cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo

Cognizant’s AI and industry expertise, combined with the NVIDIA BioNeMo generative AI platform, create a strong foundation to improve outcomes in the healthcare and life sciences sectors

TEANECK, N.J., March 19, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry, such as improving productivity in the development process and increasing the speed at which new, life-saving treatments can be brought to market.

Traditional drug discovery methodologies are process intensive and require the analysis of vast repositories of scientific literature and clinical data in order to reveal relevant insights. Moreover, traditional methods are burdened with high costs and long development lifecycles with a high rate of failure. By leveraging gen AI technologies, clinical researchers can rapidly sift through extensive datasets, more accurately predict interactions between drug compounds and create new, viable drug development pathways. 

“More than any other technological breakthrough in recent decades, generative AI has the potential to revolutionize the way new drugs are researched, developed and brought to market, making the creation of lifesaving discoveries faster, smarter and more accessible to all,” said Anna Elango, EVP, Cognizant’s Core Technologies & Insights. “By collaborating with NVIDIA, Cognizant can open the path to realizing this vision safely, responsibly and cost-effectively for our life sciences clients.”

By leveraging its deep life sciences and AI domain expertise and NVIDIA’s pretrained, industry-specific generative AI models offered as part of BioNeMo, Cognizant aims to give clients access to a suite of model-making services, including pretrained models, cutting-edge frameworks, and APIs, that offers clients the quickest path to train and customize enterprise models using their proprietary data. The offering is intended to enable this with reduced manual intervention for data analysis, and without the need to write elaborate code and build or maintain infrastructure.

“Generative AI will drive the next wave of enterprise productivity gains across industries, enabled by the NVIDIA AI Enterprise software platform,” said Alvin DaCosta, VP, Global Consulting Partner Organization, NVIDIA. “Using NVIDIA BioNeMo, Cognizant will help provide its life sciences clients with advanced, secure and reliable AI services to drive improved outcomes with custom drug discovery applications.”

Cognizant collaborates with leading global firms in pharmaceuticals, biotech and medical devices, covering the entire life sciences value chain from R&D to digital health. This work contributes to the industry’s ability to enhance science, improve patient outcomes, and increase business value, by enabling a patient-centric approach and better interactions with healthcare professionals. Cognizant’s life sciences offerings support more than 120 global manufacturing lines and more than 18 million patients with medical device company products. 

Cognizant intends to pursue additional applications by collaborating with NVIDIA in areas such as manufacturing and automotive engineering, where gen AI has the potential to enhance productivity, optimize costs and bring innovation to market more quickly. Cognizant intends to establish an NVIDIA AI Center of Excellence this year to further innovate with NVIDIA technologies, including the NVIDIA Metropolis, NVIDIA Omniverse and NVIDIA AI Enterprise platforms, for the benefit of clients across industries around the world.

About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we’re improving everyday life. See how at www.cognizant.com or @cognizant.

For more information, contact:

U.S.

Name Ben Gorelick

Email 
[email protected] 

Europe / APAC

Name Christina Schneider

Email
[email protected] 

India

Name Rashmi Vasisht

Email
[email protected] 

Logo – https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo-302092233.html

Continue Reading

Fintech PR

ICP DAS-BMP Secures Pivotal TPU Deals with Medical Materials Leaders in U.S. and Japan, Boosts Product Reliability

Published

on

icp-das-bmp-secures-pivotal-tpu-deals-with-medical-materials-leaders-in-us.-and-japan,-boosts-product-reliability

HSINCHU, March 19, 2024 /PRNewswire/ — ICP DAS-BMP dazzled at the prestigious MD&M West Show, where its high-quality medical-grade thermoplastic polyurethane (TPU) garnered orders from top manufacturers in U.S. and Japan. Concurrently, part of the company’s TPU products passed the ISO10993-6 test for local effects after 90-day implantation, positioning them as ideal materials for producing indwelling medical devices intended for use over 30 days.

ICP DAS-BMP, Asia’s first medical-grade TPU supplier, produces three main series of products: Alithane™ (ALP series), Durathane™ (ALC series), and Arothane™ (ARP series). The company is set to launch a new Durathane™ (ARC series), known for its exceptional biostability. All the TPU series are available in different hardness levels, colors, and concentrations of radiopaque fillers (Tungsten/Barium Sulfate). These materials are widely utilized in manufacturing cardiovascular, urological, and gastrointestinal devices, as well as medical and electromedical consumables.

ICP DAS-BMP’s Arothane™ ARP-B20 (20% Barium Sulfate) and Durathane™ ALC-B40 (40% Barium Sulfate) passed the ISO10993-6 90-day implantation test. This qualifies them for long-term invasive or implantable medical applications such as peripherally inserted central catheters (PICC) and port-a-cath. The company plans to conduct long-term implantation tests for other specifications of TPU products based on customer demand, while advancing research and development to uphold TPU product quality.

ICP DAS-BMP Medical Grade TPU Biocompatibility and Other Testing

Medical-grade TPU differs from other plastics by emitting minimal VOCs during manufacturing and having low wastewater discharge, making it extremely environmentally friendly. It contains no plasticizers or heavy metals, ensuring excellent biocompatibility and blood compatibility, and enhancing ESG sustainability. ICP DAS-BMP aims to offer safer, stable, and eco-friendly medical-grade TPU, collaborating with global medical device manufacturers to create long-term benefits and value.

Meet the company’s experts at:

CMEF (ICMD) 2024 (April 11-14) 
Booth Hall 8.1, M44, M46
NECC (Shanghai), China

Medtec Japan 2024 (April 17-19) 
Booth 2022
Tokyo Big Sight East 2~3 Hall, Japan

About ICP DAS-BMP

ICP DAS-BMP, a Taiwan-based TPU manufacturer and supplier certified with ISO 13485, operates specialized laboratories dedicated to quality management. Drawing upon three decades of industrial automation expertise from its parent company ICP DAS, ICP DAS-BMP has implemented smart factory practices to enhance product quality and expedite delivery times. Additionally, the company provides responsive after-sales support and offers flexible solutions for small order quantities.

For more information, please visit: https://bmp.icpdas.com/

For TPU products and inquiries, contact: [email protected]

ICP DAS – BMP

Photo – https://mma.prnewswire.com/media/2364434/ICP_DAS_BMP_Secures_Pivotal_TPU_Deals_with_Medical_Materials_Leaders_in_U_S__and_Japan__Boosts_Produ.jpg
Photo – https://mma.prnewswire.com/media/2364438/ICP_DAS_BMP_Medical_Grade_TPU_Biocompatibility_and_Other_Testing.jpg
Logo – https://mma.prnewswire.com/media/2261949/ICP_DAS___Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/icp-das-bmp-secures-pivotal-tpu-deals-with-medical-materials-leaders-in-us-and-japan-boosts-product-reliability-302091445.html

Continue Reading

Trending